Specialized IP focus RMMS is a boutique law firm with a focused practice on life sciences patent and regulatory counseling, patent litigation, and PTAB post-grant review, suggesting opportunities to cross-sell advanced IP strategy and regulatory support to pharma and biotech clients.

Notable recognition Recent Tier 1 and leading firm designations from Legal 500 and Chambers in 2026, along with LSPN IP Boutique of the Year acknowledgment in 2025, signal strong credibility with potential clients seeking top-tier life sciences IP counsel.

Growing scale Firm comprises over 30 attorneys serving a diverse pharmaceutical docket across more than 300 litigation matters, indicating capacity for expanded engagements, larger portfolios, and cross-case collaboration opportunities with mid-market to large pharma companies.

Strategic tech stack Adoption of cloud and collaboration tools such as AWS, Azure, Office 365, iCIMS, WordPress, and analytics tools aligns with modernized client service delivery; potential upsell of secure collaboration platforms, data analytics for IP portfolios, and scalable matter management.

Revenue footprint Reported revenue in the 10–25 million range places RMMS as a nimble, high-specialization firm that could be a compelling partner for larger firms seeking boutique IP excellence or for pharma clients migrating IP strategy from general practice to specialist counsel.